Clinical trial
Safety Study of ORG 34517 for Major Depression With Psychotic Features
NCT00226278 · Weill Medical College of Cornell University, Other · Completed
Key facts
| NCT number | NCT00226278 |
|---|---|
| Title | Safety Study of ORG 34517 for Major Depression With Psychotic Features |
| Official title | Prospective, Double Blind, Randomized, Placebo-Controlled Dose Finding Study of the Efficacy and Safety of 2 Target Doses of Org 34517 Used as Adjunct" |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Psychotic Disorders |
| Intervention type | Drug |
| Interventions | ORG 34517 |
| Enrollment | 25 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 26, 2005 |
| Last update posted | Mar 31, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: